School of Engineering
Vascular Engineering and Applied Biomedicine Group
(GEVAB)
2021 SGR 00524
The GEVAB group develops its activity in two main areas: the development of biomaterials to treat vascular pathologies and the study of other clinical needs, integrating knowledge from medicine, biology, chemistry, physics, mathematics and computing.
The GEVAB group has been recognised by AGAUR as a Consolidated Research Group since 2021.
GEVAB mainly studies vascular diseases such as arteriosclerosis or aneurysms. At the same time, it devotes its efforts to understanding the interaction between blood vessels and the organs they feed, as in the case of the blood-brain barrier. The main strategic objectives of the group are to establish a continuous dialogue between its researchers so that clinical needs can guide the elucidation of the fundamental mechanisms of vascular disease, to enable the findings of the molecular and cellular mechanisms of the disease to be used to change medical practices, and, finally, to exchange researchers, technologies, and experience with the group’s network of international partners to ensure that the knowledge developed in Barcelona is applicable and implementable elsewhere.
In this environment, GEVAB carries out its R&D and technology transfer activities in the following areas:
- Development of biomaterials for scaffolds
- Development of bioabsorbable biomimetic adhesive patches
- Interaction between blood vessels and the corresponding recieving organs (BBB)
- Development of drug delivery systems
- Solutions in the medical biotechnology industry (medical and pharmaceutical accessories)
- Development of materials to treat arteriosclerosis and aneurysms
COORDINATOR:
MEMBERS:
EXTERNAL COLABORATORS
Gaspar Mestres, PhD
Hospital Clínic de Barcelona
Vincent Riambau, PhD
Hospital Clínic de Barcelona
Elazer Edelman, PhD
Massachussets Institute of Technology, EE.UU
BUSINESS SOLUTION AREAS
LINKED NEWS
Doctoral thesis
New Endovascular Patch Implantation System
13/11/2023
Dr Alejandro Aranda recently defended his doctoral thesis at IQS, in which he designed and manufactured a new system for implanting a patch inside a human aorta that includes a guide catheter, a transport catheter, and the deployment of the patch.
READ FULL NEW
Research
New Effective Therapies for Multiple Sclerosis
11/10/2023
The IQS GEVAB group forms part of the European IMMUTOL project, which aims to develop and validate an advanced immunotherapeutic product based on tolerogenic dendritic cells for the treatment of multiple sclerosis.
READ FULL NEW
Interview
Interview with Francesc Canalejo, IQS Predoctoral Researcher
05/10/2023
Francesc Canalejo Codina, a doctoral student in the Department of Industrial Engineering at IQS, has earned a grant from the Daniel Bravo Andreu Private Foundation to conduct biomedical research at MIT.
READ FULL NEW
Research
Bypass for Heart Patients Using Donor Veins
04/07/2023
This research promoted by BST, IGTP, and IQS could lead to a therapeutic and innovative alternative that aims to obtain a human-origin biological bioimplant called VASCRAFT for coronary bypass.
READ FULL NEW
Doctoral thesis
Plasmin Inhibitors in Brain Trauma Treatments
05/05/2023
Dr Oriol Bosch Sanz recently defended his doctoral thesis at IQS, in which he explored obtaining new candidates for inhibitors of the plasminogen/plasmin system to reduce the damage produced in the blood-brain barrier as a result of brain trauma.
READ FULL NEW
Doctoral thesis
A Bioabsorbable Patch to Treat Aortic Dissection
16/05/2022
In her doctoral thesis conducted at IQS, Dr Noemí Balà has designed a specific device to treat aortic dissection featuring mechanical properties similar to those of the artery, making it possible to improve current treatments.
READ FULL NEW
News
A Highly Innovative and Entrepreneurial Unit
19/04/2022
Within the field of Advanced Materials, IQS has created various spinoffs thanks to the innovative and entrepreneurial spirit of numerous professors and researchers at the university.These initiatives are a clear example of the importance of knowledge transfer from the academic and higher education world to industry.
READ FULL NEW
News
Nanotechnology and Advanced Materials Unit: Services for Industry
19/04/2022
The R&D&i services and technology transfer offered by IQS Tech Transfer to companies has grown even greater since the end of 2019 through the launch of the Nanotechnology and Advanced Materials Unit located within the Process Transfer and Integrative Technologies Centre (CTPTI) at IQS.
READ FULL NEW
News
Nanotechnology and Advanced Materials Unit: Equipment
19/04/2022
The Nanotechnology and Advanced Materials Unit within the Process Transfer and Integrative Technology Transfer Centre (CTPTI) at IQS boasts several laboratories equipped for research and technology transfer activities mainly related to particle and cell characterization and the analysis and characterization of polymeric materials, biomaterials, ceramic materials, and graphene, among others.
READ FULL NEW
Research
Aortyx Receives €2.5 Million Euros from the European Commission’s EIC Accelerator Programme
14/02/2022
The IQS spinoff company, Aortyx, has received €2.5 million euros in "Grant first" funding through the European Innovation Council (EIC) Accelerator Programme. Also, Dr Inés Moreno received one of the prestigious Torres Quevedo Grants at the end of 2021 to conduct her research in this spinoff company.
READ FULL NEW
Research
New 3D printer at IQS to manufacture arterial models
17/12/2021
The IQS Industrial Products Engineering Laboratory equipment has been expanded with the recent incorporation of the Form 3BL 3D printer, for the manufacture of full-scale polymeric arteries.
READ FULL NEW
Research
Development of a new endovascular medical device
26/10/2021
Within the Collaboration Challenges program, Aortyx and the GEMAT group collaborate in the development and preclinical validation of a new endovascular medical device with localized and controlled release of anti-progression drugs for aneurysms.
READ FULL NEW
Research
Adhesive patch for arterial repairs
05/02/2021
IQS researchers of the Endovascular Repair Patch project, carried out within the AGAUR 'Product' call, have achieved both the definitive design of the deployer and the biocompatible materials that allow the administration of a patch for the repair of arteries affected by aortic dissection .
READ FULL NEW
LATEST PROJECTS
IMMUTOL (Advanced antigen-specific dendritic cell-based therapy to re-establish tolerance in immunemediated diseases)
IMMUTOL is the Accelerated development and validation of an advanced therapeutic drug (ATMP) based on modified VitD3
Funding Agency:
Research Group Link:
Vascular Engineering and Applied Biomedicine Group (GEVAB)
PolyCoarct (Stents poliméricos adaptables para tratar coarctación aórtica pediátrica)
Stents poliméricos adaptables para tratar coarctación aórtica pediátrica.
Funding Agency:
Research Group Link:
Vascular Engineering and Applied Biomedicine Group (GEVAB)
VasCraft (Nuevo injerto humano vascular descelularizado y re-endotelizado producido mediante ingeniería de tejidos para su uso en derivación arterial)
Desarrollo de un injerto venoso para generar un producto de terapia avanzada bajo condiciones Good Manufacturing Practice (GMP), el bioimplante VasCraft para tratar la cirugía de revascularización coronaria
Funding Agency:
Research Group Link:
Vascular Engineering and Applied Biomedicine Group (GEVAB)
